Disappearance of honeycomb opacity of Thiel-Behnke corneal dystrophy after Thygeson superficial punctate keratitis

Cornea. 2005 Nov;24(8):1029-30. doi: 10.1097/01.ico.0000160974.81200.40.

Abstract

Purpose: To present an unusual case in which the honeycomb opacities of Thiel-Behnke corneal dystrophy disappeared during a course of chronic Thygeson superficial punctate keratitis.

Case: A 29-year-old woman with a 5-year history of decreased visual acuity in both eyes had bilateral honeycomb-shaped corneal opacities, located mainly in the superficial central cornea. She was diagnosed as having Thiel-Behnke corneal dystrophy, which we confirmed genetically. During follow-up, her left eye was affected by chronic Thygeson superficial punctate keratitis, and the honeycomb opacity in this eye was noted to have disappeared.

Conclusions: We observed the dissolution of honeycomb-like corneal opacities in a patient with confirmed Thiel-Behnke corneal dystrophy after the patient subsequently contracted chronic Thygeson superficial punctate keratitis. We surmise that epithelial inflammation associated with Thygeson epithelial keratitis may play a role in dissolving the honeycomb opacities.

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / therapeutic use
  • Adult
  • Cornea / pathology*
  • Corneal Dystrophies, Hereditary / complications*
  • Corneal Dystrophies, Hereditary / pathology
  • Corneal Opacity / etiology*
  • Corneal Opacity / pathology
  • Drug Therapy, Combination
  • Female
  • Fluorometholone / administration & dosage
  • Fluorometholone / therapeutic use
  • Follow-Up Studies
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / therapeutic use
  • Keratitis / complications*
  • Keratitis / drug therapy
  • Keratitis / pathology
  • Ophthalmic Solutions
  • Remission, Spontaneous

Substances

  • Adjuvants, Immunologic
  • Glucocorticoids
  • Ophthalmic Solutions
  • Hyaluronic Acid
  • Fluorometholone